Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...

One analyst noted that negative price movement in Chicago soyoil and European rapeseed were pressuring canola prices, with the latter showing poor crop conditions. While small losses in crude oil ...

Preston Caldwell is senior U.S. economist for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, ...

Hungary's central bank announces a rate decision on Tuesday. Analysts at UniCredit Research expect a 25 basis-point cut in Hungary's policy rate, from 6.75% currently, particularly given the central ...

In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.

But passing up the opportunity to size up changes in your current coverage and compare your plan options could be particularly perilous this year, given all the benefit changes afoot, experts say.

It comes after sales in July climbed 0.9% from the month before to a seasonally adjusted 66.38 billion Canadian dollars, the equivalent of about US$48.95 billion. That was strongest advance in 10 ...

Tech stocks could be poised for a boost as Apple Inc.'s weighting in the S&P 500 is set to increase, while Palantir and Dell are due to be added Investors are facing the busiest quarterly rebalancing ...

Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, making it the first drug cleared in the U.S. for the rare neurodegenerative disorder.

An interesting shift has happened in the used-car market over the course of 2024: Used electric vehicles, which had long been priced at a premium, have gradually become cheaper than their gas-engine ...

"The Munich Regional Court in Germany has ruled that Amazon is using Nokia's patented video-related technologies in its end user streaming devices and is selling them illegally without a license," a ...

FedEx Corp.'s big earnings-target miss may be more of a speed bump than a brick wall, one analyst said Friday, as the package deliver giant's stock fell sharply after a reduced earnings forecast and ...